Alex Young; Eamon N. Dreisbach; Anthony DeFino , 2025-05-06 13:28:00
SALT LAKE CITY — In this Healio Video Perspective from the ARVO meeting, Paolo S. Silva, MD, discusses a study comparing ultrawide field red-green vs. red-green-blue imaging for determining the severity of diabetic retinopathy.
“Based on our study of 95 eyes in 47 patients, we’ve seen that there is virtually no difference in the RG and RGB imaging devices in its ability to predict and identify the severity of retinopathy present in these eyes,” he said.
Sources/Disclosures
Collapse
Tiskaoglu N, et al. Comparison of red-green and red-green-blue ultrawide field imaging for assessing diabetic retinopathy severity. Presented at: Association for Research in Vision and Ophthalmology meeting; May 4-8, 2025; Salt Lake City.
Disclosures:
Silva reports that the study was funded by Optos via a grant to the Beth Israel Lahey Health Joslin Diabetes Center.
